Published online Mar 26, 2015. doi: 10.4330/wjc.v7.i3.119
Peer-review started: December 4, 2014
First decision: December 12, 2014
Revised: December 24, 2014
Accepted: January 15, 2015
Article in press: January 19, 2015
Published online: March 26, 2015
Processing time: 99 Days and 23.1 Hours
Core tip: Clinical outcomes in coronary artery disease with type 2 diabetes mellitus (T2DM) are poor despite improvements in medications and other interventions. Although coronary artery bypass grafting is superior to percutaneous coronary intervention in multivessel coronary artery disease with T2DM, selecting the revascularization strategy depends not only on the lesion complexity but also on the patient’s medical history and comorbidities. In these patients, comprehensive risk management with medical and non-pharmacological therapies is indispensable, and confirming whether such risk management is being appropriately achieved is also important. Furthermore, interventions with exercise and diet therapy during the early stages of glucose abnormalities might be effective in preventing the development or progression of T2DM and in reducing the occurrence of cardiovascular events.
